Measles Virus Mutations Don't Undermine Vaccine Efficacy, ICDDR,B Study Finds
A study by the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) indicates that genetic changes in the measles virus currently causing an outbreak in Bangladesh have not rendered existing vaccines ineffective. Initial findings suggest that the virus has not undergone mutations significant enough to evade vaccine-induced immunity. The research aimed to address questions about vaccine efficacy due to the outbreak's scale. However, the study found that the most affected group comprises infants under nine months old, who are not yet eligible for the regular vaccination schedule. Between March 15, 2026, and July 25, 2026, Bangladesh reported 122,763 suspected and 15,272 confirmed measles cases, with 721 deaths from symptoms and 95 confirmed deaths. A joint investigation by ICDDR,B and Bangladesh Shishu Hospital and Institute from April 20 to May 21, 2026, analyzed 341 children under 14 admitted with measles symptoms, confirming measles in 324. The highest incidence was observed in children aged three to eight months. Researchers attribute this vulnerability to the rapid decline of maternal antibodies and the first vaccine dose not being administered until nine months of age. Among children under nine months without vaccination eligibility, 97.3% tested positive. Those who had not received any doses despite being eligible showed a 97% positive rate. Children with one dose had a 92% positive rate, while those with two recommended doses had a 76% positive rate, suggesting the vaccine remains effective. The study analyzed 55 full genome sequences of the B3 genotype virus, common globally, identifying four mutations in the H protein's epitope region, which aids viral entry into human cells. However, no evidence suggests these mutations allow the virus to escape vaccine protection, as it remains a single serotype recognized by vaccine-induced antibodies. ICDDR,B plans further extensive research to understand why vaccinated children contract the disease and when maternal antibodies wane, emphasizing the importance of timely vaccination for all children.
The study's findings suggest that while measles outbreaks persist, the underlying viral genetics have not fundamentally compromised the efficacy of established vaccination protocols. The higher infection rates observed in unvaccinated or partially vaccinated infants highlight the critical importance of adhering to national immunization schedules, particularly for age groups most vulnerable due to waning maternal immunity and delayed first doses. The identification of viral mutations, while noted, has not yet translated into a demonstrable escape from vaccine-induced immune responses, indicating the continued robustness of current vaccine technology. Future research should focus on systemic factors contributing to vaccination gaps and potential waning immunity, rather than solely on viral evolution, to ensure sustained public health protection against measles.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.